Individual Tumor Profiling
Has Tumor Molecular Profiling Enabled More Effective and Less Toxic Cancer Treatment?
Top 10 Under 40
Up-and-Coming Stars Shine in Biopharma Research and Business
Podcast: FDA’s New Commissioner Hits the Ground Running
Scott Gottlieb, M.D., Commits to Speeding Up Drug Reviews, and Maintaining Safety and Efficacy
Liquid Biopsies Remain Wait and See for Some Clinicians
Circulating Biomarker Assays Promise to Refresh Cancer Profiling and Monitoring Practices
The Sunshine Act
The Centers for Medicare & Medicaid Services (CMS) is collecting, aggregating, and going to publish data on payments to providers, as required under Obamacare. CMS is supposed to launch a public website with the data by September 30, 2014. (Learn more about this here.) What are your thoughts on the new law?